Zymeworks (ZYME) Non Operating Income (2021 - 2026)

Zymeworks' (ZYME) quarterly Non Operating Income came in at $120000.0 in Q1 2026, up 144.9% year-on-year from $49000.0 in Q1 2025, and up 139.74% quarter-over-quarter from -$302000.0 in Q4 2025.

Zymeworks (ZYME) Non Operating Income (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Non Operating Income across 6 years of filings, most recently posting $120000.0 for Q1 2026.

  • Non Operating Income for Q1 2026 came in at $120000.0, up 144.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$488000.0 (down 261.06% YoY), and the FY2025 annual result was -$559000.0, down 200.18% from the prior year.
  • Non Operating Income came in at $120000.0 for Q1 2026 at Zymeworks, up from -$302000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.4 million in Q3 2022 to a low of -$832000.0 in Q4 2023.
  • The 5-year median for Non Operating Income is $49000.0 (2025), against an average of $19705.9.
  • Across the five-year window, Non Operating Income slumped 2406.67% in 2022 and jumped 254.41% in 2025, its largest moves.
  • Zymeworks' Non Operating Income stood at -$692000.0 in 2022, then dropped by 20.23% to -$832000.0 in 2023, then surged by 141.35% to $344000.0 in 2024, then slumped by 187.79% to -$302000.0 in 2025, then soared by 139.74% to $120000.0 in 2026.
  • The last three Non Operating Income figures came in at $120000.0 (Q1 2026), -$302000.0 (Q4 2025), and $315000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - 120,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 120,000.00
Dec 31, 2025 -302,000.00
Sep 30, 2025 315,000.00
Jun 30, 2025 -621,000.00
Mar 31, 2025 49,000.00
Dec 31, 2024 344,000.00
Sep 30, 2024 -204,000.00
Jun 30, 2024 114,000.00
Mar 31, 2024 304,000.00
Dec 31, 2023 -832,000.00
Sep 30, 2023 634,000.00
Jun 30, 2023 -209,000.00
Mar 31, 2023 -487,000.00
Dec 31, 2022 -692,000.00
Sep 30, 2022 1.36 Mn
Jun 30, 2022 759,000.00
Mar 31, 2022 -315,000.00
Dec 31, 2021 30,000.00
Sep 30, 2021 1.15 Mn